STRAWBEAR ENT Announces New Authorized Representative Appointment

Stock News
Yesterday

STRAWBEAR ENT (02125) has issued a formal announcement detailing a change in corporate roles. Ms. Zhang Xiao has resigned from her positions as joint company secretary, authorized representative, and legal process agent, effective August 26, 2026, due to work arrangements.

The board has confirmed that Mr. Liu Xiaofeng, the company's board chairman, executive director, and chief executive officer, has been appointed as the new authorized representative. Concurrently, Ms. Yip Man Wai has been named the legal process agent to succeed Ms. Zhang, both appointments taking effect from the same date of August 26, 2026.

The transition is part of the company's ongoing corporate governance adjustments, ensuring continuity in these key administrative functions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10